Skip to content

Powered Echelon Device in VATS Surgery

A Prospective, Multi-Center Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01843192
Enrollment
71
Registered
2013-04-30
Start date
2013-05-31
Completion date
2014-05-31
Last updated
2015-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer (NSCLC)

Brief summary

This study aims to collect real world outcomes of Video-Assisted Thoracoscopic Surgery (VATS) for lung cancer (lobectomy, wedge resection) using ECHELON FLEX™ Powered ENDOPATH® Staplers 45 mm and/or 60 mm (study devices).

Interventions

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected or confirmed NSCLC (up to and including Stage II) * Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung * Performance status 0-1 (Eastern Cooperative Oncology Group classification) * ASA score \< 3 * No prior history of VATS or open lung surgery * Willing to give consent and comply with study-related evaluation and treatment schedule

Exclusion criteria

* Active bacterial infection or fungal infection; * Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure) * Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure * Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed) * Pregnancy * Physical or psychological condition which would impair study participation; * The patient is judged unsuitable for study participation by the Investigator for any other reason; or * Unable or unwilling to attend follow-up visits and examinations

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of Postoperative Air LeaksPost-operative period through hospital discharge and follow-up at Day 30Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).
Occurrence of Prolonged Air LeaksPost-operative period through hospital discharge and follow-up at Day 30Prolonged air leaks defined as longer than 5 days in continuous duration. Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).

Secondary

MeasureTime frameDescription
Time to Chest Tube RemovalPost-operative period through hospital discharge and follow-up at Day 30Defined as the number of days from date of surgery to removal of the last chest tube inserted during the surgical procedure.
Operative TimeDay of surgeryDefined as the duration in hours from the first skin incision to the closure of the last incision
Length of Stay (LOS)Post-operative period through hospital discharge and follow-up at Day 30Determined as the length of time in days from hospital admission to initial hospital discharge
Number of Subjects With 1 Chest Tube PlacedDuring surgeryAll subjects had either 1 or 2 chest tubes placed during surgery. Results presented are for the percentage of subjects with 1 chest tube placed.
Occurrence of Intra-operative Leak TestDuring surgeryThis outcome was scored as Yes or No based on whether a leak was detected during an intra-operative leak test when it was performed. Not all subjects had an intra-operative leak test performed, as it was not standard of care at all participating institutions, and so results are only presented for those subjects in whom an intra-operative test was performed.
Volume of Estimated Intra-operative Blood LossBlood loss intra-op and up to 5 days post-op

Countries

United States

Participant flow

Recruitment details

Individuals undergoing VATS lobectomy for suspected or confirmed Non-small Cell Lung Cancer, or individuals undergoing VATS diagnostic wedge resection in accordance with their institution's Standard of Care, and who meet study entry criteria, were enrolled in this study.

Pre-assignment details

There was no assignment to treatment group given that this is a single arm study wherein the same device was used on all subjects. Results are presented for the overall cohort as well as by the individual procedure performed - lobectomy, wedge resection, or wedge resection with lobectomy.

Participants by arm

ArmCount
Wedge Resection
Subjects undergoing VATS wedge resection
24
Lobectomy
Subjects undergoing VATS lobectomy
28
Wedge Resection With Lobectomy
Subjects undergoing VATS wedge resection that also required lobectomy
9
Total61

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyIntra-operative exclusions per protocol262

Baseline characteristics

CharacteristicWedge ResectionTotalWedge Resection With LobectomyLobectomy
Age, Continuous63.3 years
STANDARD_DEVIATION 10.02
66.3 years
STANDARD_DEVIATION 8.51
68.7 years
STANDARD_DEVIATION 5.72
68.1 years
STANDARD_DEVIATION 7.26
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants61 Participants9 Participants28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
23 Participants59 Participants9 Participants27 Participants
Region of Enrollment
United States
24 participants61 participants9 participants28 participants
Sex: Female, Male
Female
12 Participants37 Participants5 Participants20 Participants
Sex: Female, Male
Male
12 Participants24 Participants4 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
8 / 266 / 343 / 11
serious
Total, serious adverse events
2 / 264 / 342 / 11

Outcome results

Primary

Occurrence of Postoperative Air Leaks

Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).

Time frame: Post-operative period through hospital discharge and follow-up at Day 30

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (NUMBER)
Wedge ResectionOccurrence of Postoperative Air Leaks45.8 percentage of participants
LobectomyOccurrence of Postoperative Air Leaks67.9 percentage of participants
Wedge Resection With LobectomyOccurrence of Postoperative Air Leaks88.9 percentage of participants
Primary

Occurrence of Prolonged Air Leaks

Prolonged air leaks defined as longer than 5 days in continuous duration. Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).

Time frame: Post-operative period through hospital discharge and follow-up at Day 30

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (NUMBER)
Wedge ResectionOccurrence of Prolonged Air Leaks4.2 percentage of participants
LobectomyOccurrence of Prolonged Air Leaks7.1 percentage of participants
Wedge Resection With LobectomyOccurrence of Prolonged Air Leaks22.2 percentage of participants
Secondary

Length of Stay (LOS)

Determined as the length of time in days from hospital admission to initial hospital discharge

Time frame: Post-operative period through hospital discharge and follow-up at Day 30

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (MEAN)Dispersion
Wedge ResectionLength of Stay (LOS)3.7 daysStandard Deviation 1.63
LobectomyLength of Stay (LOS)4.9 daysStandard Deviation 1.7
Wedge Resection With LobectomyLength of Stay (LOS)4.8 daysStandard Deviation 1.48
Secondary

Number of Subjects With 1 Chest Tube Placed

All subjects had either 1 or 2 chest tubes placed during surgery. Results presented are for the percentage of subjects with 1 chest tube placed.

Time frame: During surgery

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (NUMBER)
Wedge ResectionNumber of Subjects With 1 Chest Tube Placed88.5 percentage of participants
LobectomyNumber of Subjects With 1 Chest Tube Placed100 percentage of participants
Wedge Resection With LobectomyNumber of Subjects With 1 Chest Tube Placed88.9 percentage of participants
Secondary

Occurrence of Intra-operative Leak Test

This outcome was scored as Yes or No based on whether a leak was detected during an intra-operative leak test when it was performed. Not all subjects had an intra-operative leak test performed, as it was not standard of care at all participating institutions, and so results are only presented for those subjects in whom an intra-operative test was performed.

Time frame: During surgery

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure. This analysis was further restricted to those subjects in whom an intra-operative leak test was actually performed, as it was not standard of care at all participating institutions.

ArmMeasureValue (NUMBER)
Wedge ResectionOccurrence of Intra-operative Leak Test0 participants
LobectomyOccurrence of Intra-operative Leak Test0 participants
Wedge Resection With LobectomyOccurrence of Intra-operative Leak Test1 participants
Secondary

Operative Time

Defined as the duration in hours from the first skin incision to the closure of the last incision

Time frame: Day of surgery

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (MEAN)Dispersion
Wedge ResectionOperative Time1.7 hoursStandard Deviation 0.68
LobectomyOperative Time2.8 hoursStandard Deviation 0.85
Wedge Resection With LobectomyOperative Time3.4 hoursStandard Deviation 1.43
Secondary

Time to Chest Tube Removal

Defined as the number of days from date of surgery to removal of the last chest tube inserted during the surgical procedure.

Time frame: Post-operative period through hospital discharge and follow-up at Day 30

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (MEAN)Dispersion
Wedge ResectionTime to Chest Tube Removal3.7 daysStandard Deviation 1.63
LobectomyTime to Chest Tube Removal4.9 daysStandard Deviation 1.7
Wedge Resection With LobectomyTime to Chest Tube Removal4.8 daysStandard Deviation 1.48
Secondary

Volume of Estimated Intra-operative Blood Loss

Time frame: Blood loss intra-op and up to 5 days post-op

Population: All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure

ArmMeasureValue (MEAN)Dispersion
Wedge ResectionVolume of Estimated Intra-operative Blood Loss31.5 millilitersStandard Deviation 56.48
LobectomyVolume of Estimated Intra-operative Blood Loss83.2 millilitersStandard Deviation 62.42
Wedge Resection With LobectomyVolume of Estimated Intra-operative Blood Loss86.1 millilitersStandard Deviation 80.15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026